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Medically unexplained symptoms in secondary care
Consider the possibility of anxiety or depression—or simply distress
The efficient use of medical resources isimportant, so the findings of Reid et al in thisissue (p 767)1 are timely, highlighting the previ›
ously undocumented number of frequent attenders at
secondary care consultations with medically unex›
plained symptoms. However, this study raises concerns
other than economic ones: there appear to be large
numbers of patients whose frequent attendance
suggests distress that is neither appropriately identified
or addressed.
The reasons for frequent attendance by such
patients are undoubtedly complex. At least for the first
consultation, attendance may reflect the referral
patterns of general practitioners. Medically unex›
plained symptoms are very common in primary care,2
but primary care physicians seem to have considerable
discomfort in managing these patients.3 Any patient
whose symptoms cannot be explained raises the
concern, “What am I missing?” Compounding this
unease is the expectation or demand of the patient for
a specialist opinion, against a background of increasing
litigation.
To clarify the nature of these patients’ problems it is
necessary to adopt a more critical analysis of each
patient’s health. A recent study showed that the way in
which patients describe their symptoms influences
detection of anxiety or depression.4 This is useful to
bear in mind in light of the fact that patients with anxi›
ety disorders are high users of medical care from spe›
cialists.5 International studies describe that half of
patients with depression report multiple unexplained
somatic symptoms, 11% denying psychological symp›
toms on direct questioning,6 and that recognition and
diagnosis of depression in primary care is associated
with significantly greater short term improvement.7
If anxiety and depression are easy to miss, what of
the more ill defined area of somatisation? A recent
study of 50 people without organic disease who were
frequent attenders at a gastroenterology clinic showed
that 45 had at least one current psychiatric diagnosis
and 24 at least two, with somatoform disorders being
the most common.8 Although rare in the general
population, patients who somatise seem to represent a
sizable population in general medical clinics, and they
probably overuse and overtax the healthcare system.9
The common feature of the somatoform disorders
is the presence of physical symptoms that suggest a
general medical illness but are not fully explained by
such an illness, the direct effects of a drug, or another
mental disorder.10 It is crucial to recognise that somati›
sation variously may represent the expression of the
bodily aspect of emotion (for example, sweating and
dry mouth associated with anxious arousal), an attribu›
tion (for example, the anxious patient who attributes
his rapid heart rate to heart disease), or, at a more basic
level, distress.11
Before we collectively sigh and refer these difficult
patients to the psychiatric service it is worth pondering
our own contribution to the problem. The tendency to
conceptualise medical problems in biological terms is
powerful, and medical practitioners are often reluctant
to explore the non›biological aspects of a patient’s
case. In part this may reflect concerns about
inadequate training, fear of being unable to help, or the
conviction that no psychological interventions would
help anyway. Patients respond to the cues offered by
health professionals and are themselves part of a
culture that continues to stigmatise mentally ill people
and those with emotional problems. Hence for a
distressed patient it is far more acceptable to present
with somatic symptoms.
The need to investigate has the effect of reinforcing
concerns about the physical nature of the problem,
and this is compounded if the patient sees a new doc›
tor at a subsequent consultation and the tests are
repeated “just to be sure.” It becomes clear there are
major costs to the healthcare system and the patient.
The challenge by Reid et al to focus on this group
of patients is timely,1 as their levels of disability appear
high. One wonders to what extent they contribute to
physician exhaustion and stress, given that it is frustrat›
ing and annoying to be confronted with patients one
cannot help or understand.3 The fact that a patient
returns many times despite being told there is no
medical explanation for his or her symptoms reflects
continuing distress and concern. Faced with such
behaviour health professionals must consider the
possibility of depression or anxiety.
In addition they need to pay careful attention to the
consultation itself. Patients with somatisation disorders
often feel that medical explanations reject the reality of
their symptoms, yet those who receive information
without blame and are provided with strategies for
coping feel empowered.12 In attempting to help this
group of patients we should reflect on our own
training, skills, and prejudices as well as broadening
our approach to clinical assessment.
Jane Turner senior lecturer in psychiatry
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Managing depression in primary care
The type of treatment matters less than ensuring it is done properly and followed up
Several recent studies have evaluated alternativeapproaches to managing depression in primarycare. The range of disease and the treatments
examined have varied widely, no doubt contributing to
the variation in results. Nevertheless, randomised trials
leave little doubt that antidepressant drugs are
efficacious in major depression,1 2 and recent evidence
suggests efficacy in dysthymia and subsyndromal
depression as well.3 But what role does counselling play
in the primary care management of patients with vari›
ous forms of depression? Recent trials in primary care
have produced conflicting results and conclusions.
The paper in this issue by Chilvers et al (p 772)4
and an earlier report from the same study5 address
three important questions about treating major
depression in primary care. Is there a difference in the
effectiveness of drugs versus counselling? Is the
non›standardised counselling provided by most men›
tal health providers effective? Does matching treatment
with patient preferences increase effectiveness? In
Chilvers et al’s study only the first question is addressed
using a randomised design. Unfortunately, small
sample sizes and difficulties in follow up urge caution
in interpreting the results. Regarding the second and
third questions, we must settle for non›experimental
comparisons within this sample and with previous
reports.
Chilvers et al conclude that generic counselling
appears to be as effective as antidepressant drugs for
major depression, though patients given drugs may
recover more quickly. There may be differences in
longer term effects as well. Tables 3 and 4 in the paper
show that patients randomised to drugs were 16%
more likely to have a “good” global outcome, 10%
more likely to ever remit, and 30% less likely to be
depressed by research diagnostic criteria. These differ›
ences in 12 month outcomes, none of which reached
statistical significance, raise a conundrum. Are the dif›
ferences between drugs and counselling in the
randomised group large enough to have implications
for practice?
Randomised controlled trials on both sides of the
Atlantic now provide evidence that different approaches
to counselling—cognitive›behavioural,6 interpersonal,1
and problem solving2— have equivalent efficacy to drugs
in treating major depression. But in these studies the
“talking therapy” is applied by protocol using specially
trained counsellors who are often monitored for adher›
ence to the protocol. Chilvers et al’s study placed few
constraints on either the drug treatment or the type of
counselling other than that the counselling should be
provided by an experienced mental health professional
in six sessions. In effect therefore they compared
non›standardised antidepressant use with non›
standardised counselling by experienced mental health
professionals in general practice. Because statistical tests
showed no significant differences in effectiveness the
authors conclude that generic counselling is effective.
Recent comparisons of more rigorously applied
non›directive and cognitive›behavioural counselling
with usual general practitioner care among a broader
range of depressed patients found both specific
therapies to be better than usual care at four months but
not at 12.7 This may suggest advantages for more
specific, standardised counselling over more generic
approaches. Only direct comparisons of generic
counselling with more standardised, specific approaches
will resolve this question.
As to the implications for practice, the results in the
patient preference group may be relevant. Over two
thirds of the patients refused randomisation because
they preferred a particular form of treatment, and
nearly two thirds of them preferred counselling. Both
the high proportion of people with a preference and
the high proportion of them preferring counselling
are consistent with other recent findings.7 8 Within the
patient preference group there were no differences in
outcomes between the groups treated with counselling
or drugs. Thus, regardless of one’s interpretation of the
randomised results, patient selected counselling or
drugs appear to be equally effective if the counselling is
provided by an experienced therapist.
It remains possible that patients without prefer›
ences will have better long term outcomes with drugs
under real world circumstances where follow up may
be sporadic. The major differences between usual care
and protocol driven care for depression are the assur›
ance of adequate intensity of treatment, whether coun›
selling or drugs, and the consistency of follow up.9 10
The low rates of assessment at 12 months in this study
illustrate the difficulties with follow up in everyday
practice. When care is organised to assure intensity and
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